Compare MVO & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MVO | MRKR |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 23.0M |
| IPO Year | N/A | 2010 |
| Metric | MVO | MRKR |
|---|---|---|
| Price | $2.85 | $1.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 326.5K | 152.9K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 17.46% | N/A |
| EPS Growth | N/A | ★ 33.61 |
| EPS | ★ 1.46 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $644.02 |
| P/E Ratio | $2.21 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.97 | $0.81 |
| 52 Week High | $6.40 | $4.07 |
| Indicator | MVO | MRKR |
|---|---|---|
| Relative Strength Index (RSI) | 60.27 | 54.95 |
| Support Level | $1.11 | $1.33 |
| Resistance Level | $3.37 | $1.69 |
| Average True Range (ATR) | 0.28 | 0.13 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 63.63 | 60.00 |
MV Oil Trust is a statutory trust. The trust was created to acquire and hold the net profits interest for the benefit of the Trust unitholders.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.